<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32883004</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus-B4 Infection Can Induce the Expression of Human Endogenous Retrovirus W in Primary Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1335</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms8091335</ELocationID><Abstract><AbstractText>Human Endogenous Retrovirus W Envelope (HERV-W ENV) mRNA or protein can be found in peripheral blood mononuclear cells (PBMCs) and exocrine pancreas of patients with type 1 diabetes (T1D). Further, previous observations have shown an association between enteroviral infection and development of T1D; specifically, coxsackievirus-B (CV-B) has been detected in the blood and pancreas of patients with T1D. Notably, viruses can activate HERV-W expression. Hence, we evaluated the effect of CV-B4 infection on HERV-W <i>ENV</i> mRNA expression. Primary human pancreatic ductal cells were obtained from five brain-dead donors. In the pancreatic cells of three donors, the HERV-W <i>ENV</i> mRNA level measured using RT-qPCR was upregulated upon CV-B4 infection. The HERV-W ENV protein was detected in the infected cells using the immunoblot assay. In human PBMCs inoculated with CV-B4 or when CV-B4 was incubated with an enhancing serum, the HERV-W <i>ENV</i> mRNA level was higher than the background RNA level. In monocyte-derived macrophages obtained from 5 of 13 donors, the HERV-W <i>ENV</i> mRNA level was higher in cultures inoculated with CV-B4 than in the control. Therefore, CV-B4 can upregulate or induce the transcription of a certain HERV-W <i>ENV</i> copy (or copies) in primary cell cultures, such as monocytes, macrophages, and pancreatic cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dechaumes</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610 Univ Lille, CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertin</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610 Univ Lille, CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sane</LastName><ForeName>Famara</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610 Univ Lille, CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levet</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geneuro Innovation, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610 Univ Lille, CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manipal Institute of Virology, Manipal Academy of Higher Education, Karnataka 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charvet</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Geneuro Innovation, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gmyr</LastName><ForeName>Val&#xe9;ry</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>U1190 Univ Lille, Inserm, CHU Lille, European Genomic Institute for Diabetes, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr-Conte</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>U1190 Univ Lille, Inserm, CHU Lille, European Genomic Institute for Diabetes, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierquin</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Geneuro Innovation, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arunkumar</LastName><ForeName>Govindakarnavar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Manipal Institute of Virology, Manipal Academy of Higher Education, Karnataka 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattou</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>U1190 Univ Lille, Inserm, CHU Lille, European Genomic Institute for Diabetes, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perron</LastName><ForeName>Herv&#xe9;</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Geneuro Innovation, 69008 Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geneuro SA, 1228 Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de M&#xe9;decine La&#xeb;nnec, Universit&#xe9; de Lyon, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hober</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610 Univ Lille, CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PBMCs</Keyword><Keyword MajorTopicYN="N">endogenous retrovirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">pancreatic cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32883004</ArticleId><ArticleId IdType="pmc">PMC7563422</ArticleId><ArticleId IdType="doi">10.3390/microorganisms8091335</ArticleId><ArticleId IdType="pii">microorganisms8091335</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grandi N., Cadeddu M., Blomberg J., Tramontano E. Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes. Retrovirology. 2016;13:67. doi: 10.1186/s12977-016-0301-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-016-0301-x</ArticleId><ArticleId IdType="pmc">PMC5016936</ArticleId><ArticleId IdType="pubmed">27613107</ArticleId></ArticleIdList></Reference><Reference><Citation>Belshaw R., Katzourakis A., Paces J., Burt A., Tristem M. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol. Biol. Evol. 2005;22:814&#x2013;817. doi: 10.1093/molbev/msi088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msi088</ArticleId><ArticleId IdType="pubmed">15659556</ArticleId></ArticleIdList></Reference><Reference><Citation>Levet S., Medina J., Joanou J., Demolder A., Queruel N., R&#xe9;ant K., Normand M., Seffals M., Dimier J., Germi R., et al. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. JCI Insight. 2017;2:e94387. doi: 10.1172/jci.insight.94387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.94387</ArticleId><ArticleId IdType="pmc">PMC5621895</ArticleId><ArticleId IdType="pubmed">28878130</ArticleId></ArticleIdList></Reference><Reference><Citation>Frendo J.L., Olivier D., Cheynet V., Blond J.L., Bouton O., Vidaud M., Rabreau M., Evain-Brion D., Mallet F. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol. Cell Biol. 2003;23:3566&#x2013;3574. doi: 10.1128/MCB.23.10.3566-3574.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.10.3566-3574.2003</ArticleId><ArticleId IdType="pmc">PMC164757</ArticleId><ArticleId IdType="pubmed">12724415</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J., Perron H., Feschotte C. Variation in proviral content among human genomes mediated by LTR recombination. Mob. DNA. 2018;9:36. doi: 10.1186/s13100-018-0142-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-018-0142-3</ArticleId><ArticleId IdType="pmc">PMC6298018</ArticleId><ArticleId IdType="pubmed">30568734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildschutte J.H., Williams Z.H., Monesion M., Subramanian R.P., Kidd J.M., Coffin J.M. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc. Natl. Acad. Sci. USA. 2016;113:E2326&#x2013;E2334. doi: 10.1073/pnas.1602336113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1602336113</ArticleId><ArticleId IdType="pmc">PMC4843416</ArticleId><ArticleId IdType="pubmed">27001843</ArticleId></ArticleIdList></Reference><Reference><Citation>Levet S., Charvet B., Bertin A., Deschaumes A., Perron H., Hober D. Human endogenous retroviruses and type 1 diabetes. Curr. Diabetes Rep. 2019;19:141. doi: 10.1007/s11892-019-1256-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-019-1256-9</ArticleId><ArticleId IdType="pmc">PMC6872510</ArticleId><ArticleId IdType="pubmed">31754894</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N., Tramontano E. HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity. Front. Microbiol. 2018;9:462. doi: 10.3389/fmicb.2018.00462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00462</ArticleId><ArticleId IdType="pmc">PMC5861771</ArticleId><ArticleId IdType="pubmed">29593697</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudek T., Luhdorf P., Christensen T., Hansen H.J., Moller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV- 6 and VZV. J. Neuroimmunol. 2007;187:147&#x2013;155. doi: 10.1016/j.jneuroim.2007.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.04.003</ArticleId><ArticleId IdType="pubmed">17493688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruprecht K., Obojes K., Wengel V., Gronen F., Kim K.S., Perron H., Schneider-Schaulies J., Rieckmann P. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: Implications for multiple sclerosis. J. Neurovirol. 2006;12:65&#x2013;71. doi: 10.1080/13550280600614973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280600614973</ArticleId><ArticleId IdType="pubmed">16595376</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B., Reynaud J.M., Gourru-Lesimple G., Perron H., Marche P.N., Horvat B. Induction of proinflammatory multiple sclerosis-associated retrovirus envelope protein by human herpesvirus- 6A and CD46 receptor engagement. Front. Immunol. 2018;9:2803. doi: 10.3389/fimmu.2018.02803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02803</ArticleId><ArticleId IdType="pmc">PMC6291489</ArticleId><ArticleId IdType="pubmed">30574140</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung W.C., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35. doi: 10.1136/bmj.d35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d35</ArticleId><ArticleId IdType="pmc">PMC3033438</ArticleId><ArticleId IdType="pubmed">21292721</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K., Lynch K.F., Wong M.C., Tian X., Ross M.C., Gibbs R.A., Ajami N.J., Petrosino J.F., Rewers M., Toppari J., et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 2019;25:1865&#x2013;1872. doi: 10.1038/s41591-019-0667-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane H., Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008;34:537&#x2013;548. doi: 10.1016/j.diabet.2008.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2008.05.008</ArticleId><ArticleId IdType="pubmed">18951821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Delwart E., Gorbalenya A.E., Hovi T., King A.M.Q., Knowles N.J., Lindberg A.M., Pallansch M.A., Palmenberg A.C., Reuter G., et al. ICTV Virus Taxonomy Profile: &#x201c;Picornaviridae&#x201d;. J. Gen. Virol. 2017;98:2421&#x2013;2422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D., Sauter P. Pathogenesis of type 1 diabetes mellitus: Interplay between enterovirus and host. Nat. Rev. Endocrinol. 2010;6:279&#x2013;289. doi: 10.1038/nrendo.2010.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2010.27</ArticleId><ArticleId IdType="pubmed">20351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Riabi S., Harrath R., Gaaloul I., Bouslama L., Nasri D., Aouni M., Pillet S., Pozzetto B. Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and decay-accelerating factor using human CaCo-2 cell line. J. Biomed. Sci. 2014;21:50. doi: 10.1186/1423-0127-21-50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-50</ArticleId><ArticleId IdType="pmc">PMC4035751</ArticleId><ArticleId IdType="pubmed">24885774</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L., Edwin B., Buanes T., Frisk G., Skog O., Anagandula M., Undlien D., Eike M.C., Richardson S.J., Leete P., et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64:1682&#x2013;1687. doi: 10.2337/db14-1370.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., Sane F., Lefevre C., Baras A., Moumna I., Engelmann I., Vantyghem M.C., Hober D. Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR. Acta Diabetol. 2017;54:1025&#x2013;1029. doi: 10.1007/s00592-017-1041-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-017-1041-7</ArticleId><ArticleId IdType="pubmed">28861621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylipaasto P., Klingel K., Lindberg A.M., Otonkoski T., Kandolf R., Hovi T., Roivainen M. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004;47:225&#x2013;239. doi: 10.1007/s00125-003-1297-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-003-1297-z</ArticleId><ArticleId IdType="pubmed">14727023</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., Engelmann I., Bossu J., Villenet C., Figeac M., Romond M.-B., Sane F., Hober D. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes. Virulence. 2017;8:1229&#x2013;1244. doi: 10.1080/21505594.2017.1284735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1284735</ArticleId><ArticleId IdType="pmc">PMC5711397</ArticleId><ArticleId IdType="pubmed">28112573</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I., Alidjinou E.K., Bertin A., Bossu J., Villenet C., Figeac M., Sane F., Hober D. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells. Cell Mol. Life Sci. 2017;74:3851&#x2013;3861. doi: 10.1007/s00018-017-2567-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2567-0</ArticleId><ArticleId IdType="pmc">PMC11107484</ArticleId><ArticleId IdType="pubmed">28601984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W., Lobert P.E., Sauter P., Goffard A., Lucas B., Weill J., Vantyghem M.C., Alm G., Pigny P., Hober D. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J. Virol. 2005;79:13882&#x2013;13891. doi: 10.1128/JVI.79.22.13882-13891.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.22.13882-13891.2005</ArticleId><ArticleId IdType="pmc">PMC1280186</ArticleId><ArticleId IdType="pubmed">16254324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D., Chehadeh W., Bouzidi A., Wattr&#xe9; P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-&#x3b1; synthesis. J. Infect. Dis. 2001;184:1098&#x2013;1108. doi: 10.1086/323801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/323801</ArticleId><ArticleId IdType="pubmed">11598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., San&#xe9; F., Engelmann I., Hober D. Serum-dependent enhancement of coxsackievirus B4-induced production of IFN&#x3b1;, IL-6 and TNF&#x3b1; by peripheral blood mononuclear cells. J. Mol. Biol. 2013;425:5020&#x2013;5031. doi: 10.1016/j.jmb.2013.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.10.008</ArticleId><ArticleId IdType="pubmed">24120940</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., Chehadeh W., Weill J., Vantyghem M.C., Stuckens C., Decoster A., Hober C., Hober D. Monocytes of patients with type 1 diabetes harbour enterovirus RNA. Eur. J. Clin. Investig. 2015;45:918&#x2013;924. doi: 10.1111/eci.12485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12485</ArticleId><ArticleId IdType="pubmed">26108863</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., San&#xe9; F., Trauet J., Copin M.C., Hober D. Coxsackievirus B4 can infect human peripheral blood-derived macrophages. Viruses. 2015;7:6067&#x2013;6079. doi: 10.3390/v7112924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112924</ArticleId><ArticleId IdType="pmc">PMC4664995</ArticleId><ArticleId IdType="pubmed">26610550</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkahla M.A., Elmastour F., Sane F., Vreulx A.C., Engelmann I., Desailloud R., Jaidane H., Alidjinou E.K., Hober D. Coxsackievirus-B4E2 can infect monocytes and macrophages in vitro and in vivo. Virology. 2018;522:271&#x2013;280. doi: 10.1016/j.virol.2018.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.06.010</ArticleId><ArticleId IdType="pubmed">30056354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricordi C., Lacy P.E., Scharp D.W. Automated islet isolation from human pancreas. Diabetes. 1989;38:140&#x2013;142. doi: 10.2337/diab.38.1.S140.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.38.1.S140</ArticleId><ArticleId IdType="pubmed">2642838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sane F., Caloone D., Gmyr V., Engelmann I., Belaich S., Kerr-Conte J., Pattou F., Desailloud R., Hober D. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol. Life Sci. 2013;70:4169&#x2013;4180. doi: 10.1007/s00018-013-1383-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1383-4</ArticleId><ArticleId IdType="pmc">PMC11113870</ArticleId><ArticleId IdType="pubmed">23775130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertin A., Sane F., Gmyr V., Lobert D., Dechaumes A., Kerr-Conte J., Pattou F., Hober D. Coxsackievirus-B4 infection of human primary pancreatic ductal cell cultures results in impairment of differentiation into insulin-producing cells. Viruses. 2019;11:597. doi: 10.3390/v11070597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070597</ArticleId><ArticleId IdType="pmc">PMC6669621</ArticleId><ArticleId IdType="pubmed">31269669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009;55:611&#x2013;622. doi: 10.1373/clinchem.2008.112797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2008.112797</ArticleId><ArticleId IdType="pubmed">19246619</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B., Pierquin J., Brunel J., Gorter R., Qu&#xe9;tard C., Horvat B., Amor S., Perron H., Portoukalian J. Multiple sclerosis demyelinating lesions contain unique human endogenous retrovirus type W envelope. 2020. Under revision.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558138</ArticleId><ArticleId IdType="pubmed">33770381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D., Chehadeh W., Weill J., Hober C., Vantyghem M., Gronnier P., Wattr&#xe9; P. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-&#x3b1; by peripheral blood mononuclear cells from patients with type 1 diabetes. J. Gen. Virol. 2002;83:2169&#x2013;2176. doi: 10.1099/0022-1317-83-9-2169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-9-2169</ArticleId><ArticleId IdType="pubmed">12185270</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson W.D., Mei B., Cohn Z.A. The separation, long-term cultivation, and maturation of the human monocyte. J. Exp. Med. 1977;146:1613&#x2013;1626. doi: 10.1084/jem.146.6.1613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.6.1613</ArticleId><ArticleId IdType="pmc">PMC2181917</ArticleId><ArticleId IdType="pubmed">925613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajima S., Andreas K., Andreas N., Hans-Henning E., Jaroslav P. Differentiation of human CD14+ monocytes: An experimental investigation of the optimal culture medium and evidence of a lack of differentiation along the endothelial line. Exp. Mol. Med. 2016;48:e227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855273</ArticleId><ArticleId IdType="pubmed">27080367</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt K., Richter C., Backes C., Meese E., Ruprecht K., Mayer J. Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing. J. Virol. 2013;87:13837&#x2013;13852. doi: 10.1128/JVI.02388-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02388-13</ArticleId><ArticleId IdType="pmc">PMC3838257</ArticleId><ArticleId IdType="pubmed">24109235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mameli G., Poddighe L., Mei A., Uleri E., Sotgiu S., Serra C., Manetti R., Dolei A.l. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: Inference for multiple sclerosis. PLoS ONE. 2012;7:e44991. doi: 10.1371/journal.pone.0044991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044991</ArticleId><ArticleId IdType="pmc">PMC3459916</ArticleId><ArticleId IdType="pubmed">23028727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mameli G., Madeddu G., Mei A., Uleri E., Poddighe L., Delogu L.G., Maida I., Babudieri S., Serra C., Manetti R., et al. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: The missing link with multiple sclerosis? PLoS ONE. 2013;8:e78474. doi: 10.1371/journal.pone.0078474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0078474</ArticleId><ArticleId IdType="pmc">PMC3827255</ArticleId><ArticleId IdType="pubmed">24236019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nell&#xe5;ker C., Yao Y., Jones-Brando L., Mallet F., Yolken R.H., Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology. 2006;3:44. doi: 10.1186/1742-4690-3-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-3-44</ArticleId><ArticleId IdType="pmc">PMC1539011</ArticleId><ArticleId IdType="pubmed">16822326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Nell&#xe5;ker C., Sabunciyan S., Sabunciyan S., Yolken R.H., Jones-Brando L., Johansson A.S., Owe-Larsson B., Karlsson H. Transcriptional derepression of the ERVWE1 locus following influenza A virus infection. J. Virol. 2014;88:4328&#x2013;4337. doi: 10.1128/JVI.03628-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03628-13</ArticleId><ArticleId IdType="pmc">PMC3993755</ArticleId><ArticleId IdType="pubmed">24478419</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H., Suh M., Lalande B., Gratacap B., Laurent A., Stoebner P., Seigneurin J.M. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J. Gen. Virol. 1993;74:65&#x2013;72. doi: 10.1099/0022-1317-74-1-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-74-1-65</ArticleId><ArticleId IdType="pubmed">7678635</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovo P.A., Rabbone I., Tinti D., Galliano I., Trada M., Dapra V., Cerutti F., Bergallo M. Enhanced expression of human endogenous retroviruses in new-onset type 1 diabetes: Potential pathogenetic and therapeutic implications. Autoimmunity. 2020:1&#x2013;6. doi: 10.1080/08916934.2020.1777281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2020.1777281</ArticleId><ArticleId IdType="pubmed">32586158</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H., Jouvin-Marche E., Michel M., Ounanian-Paraz A., Camelo S., Dumon A., Jolivet-Reynaud C., Marcel F., Souillet Y., Borel E., et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology. 2001;287:321&#x2013;332. doi: 10.1006/viro.2001.1045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1045</ArticleId><ArticleId IdType="pubmed">11531410</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafon M., Jouvin-Marche E., Marche P.N., Perron H. Human viral superantigens: To be or not to be transactivated? Trends Immunol. 2002;23:238&#x2013;239. doi: 10.1016/S1471-4906(02)02207-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(02)02207-X</ArticleId><ArticleId IdType="pubmed">12102742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy R., Mohammed F., Meier U.C. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis. Immunol. Lett. 2020;217:15&#x2013;24. doi: 10.1016/j.imlet.2019.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2019.10.017</ArticleId><ArticleId IdType="pubmed">31689443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>